Welcome in, today is Monday, July twentieth, and we begin with the numbers behind K-beauty's fast climb into the American mainstream. The rise of Korean beauty in the United States is accelerating, and the data points to more room ahead. When Olive Young, South Korea's leading beauty retailer, opened its first U.S. store in Pasadena in late May, shoppers camped out and lines ran for blocks. The company says six thousand customers passed through on opening weekend, and the store now averages more than sixteen hundred visitors a day. Olive Young has since opened a second California location and says more are planned. Behind the crowds is a broader shift. According to NielsenIQ, U.S. K-beauty sales reached two point eight billion dollars early this year, up roughly forty-eight percent from a year earlier. That is faster than the prior year's pace, an acceleration one NielsenIQ analyst called unusual. Household penetration has climbed to nearly twenty-nine percent, a sign the category is becoming stickier. Analysts trace a first wave in the twenty-tens, when housebound consumers embraced multi-step routines and the glass-skin look; a skincare-first second wave, they say, is now carrying the category. Morgan Stanley's Simeon Gutman forecasts U.S. K-beauty sales near four billion dollars this year, citing demand for functional skincare and the pull of Korean culture. That momentum reads straight through to shelf space. Sephora partnered with Olive Young earlier this year, and analysts see Ulta positioned to benefit, with Korean brands like Medicube and Peach and Lily performing well; Ulta reports second-quarter results on August fifth. Industry reaction leans toward reading these stores as a curated-discovery play, and a recurring question in the trade is whether opening-day traffic converts into structural repeat purchase rather than novelty. Also today, a test of American appetite for premium skincare. UK-founded brand Medik8 is making its debut at Sephora in the United States and Canada, and, per Cosmetics Business, has outlined ambitious growth plans anchored on a stated target of one hundred million dollars in sales. It is a pointed marker for a clinical-premium label stepping onto a mass prestige floor, and one that will measure how far functional-skincare demand extends beyond its home market. North America is now the battleground where these clinical positionings get priced, and Sephora's reach gives Medik8 both distribution and a public benchmark. Industry reaction is mixed: some longtime customers voice concern that wider distribution, under L'Oréal ownership, could test the clinical positioning that anchors the brand's pricing. Separately, Bath and Body Works has opened its first store in Brazil, in São Paulo, alongside a dedicated Brazilian e-commerce site. The company frames it as the latest step in the U.S. fragrance retailer's international expansion, paired with a localized fragrance strategy for the market. Now, a few more headlines moving the trade today. Jean Paul Gaultier is launching La Favorite, its first major feminine fragrance in a decade, arriving as the brand points to surging momentum for its Le Male line, per WWD. Also per WWD, Neutrogena is retooling for a younger generation, with a recent retinol launch and a new communications platform called Break the Rules central to its second-half strategy. Chanel says global chief financial officer Philippe Blondiaux, at the privately held French house since twenty eleven, will retire on December thirty-first, twenty twenty-six. And finally, Shiseido has named Adele Zhang to lead its global travel retail business, a channel the company describes as central to its ongoing recovery.